Premier Path Wealth Partners, LLC Biogen Inc. Transaction History
Premier Path Wealth Partners, LLC
- $718 Billion
- Q2 2025
A detailed history of Premier Path Wealth Partners, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Premier Path Wealth Partners, LLC holds 9,551 shares of BIIB stock, worth $1.43 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
9,551
Previous 8,712
9.63%
Holding current value
$1.43 Million
Previous $1.19 Billion
0.62%
% of portfolio
0.17%
Previous 0.19%
Shares
7 transactions
Others Institutions Holding BIIB
# of Institutions
1,038Shares Held
131MCall Options Held
2.84MPut Options Held
2.54M-
Vanguard Group Inc Valley Forge, PA17.3MShares$2.59 Billion0.04% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$2.36 Billion1.62% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.18 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.47MShares$1.12 Billion0.04% of portfolio
-
Wellington Management Group LLP Boston, MA4.8MShares$718 Million0.11% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $21.5B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...